NCT02977013View on ClinicalTrials.gov

Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Anti-Xa Assay in Pulmonary Embolism
Interventions
DIAGNOSTIC_TEST

Anti-Xa assay

Correlation between anti-Xa assay and the efficacy and safety of enoxaparin in the treatment of pulmonary embolism

All Listed Sponsors
lead

Mohamed Sayed Mohamed Abbas

OTHER

NCT02977013 - Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism | Biotech Hunter | Biotech Hunter